1Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med,1995,333:609-614.
2Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthetase 2. Cell, 1995,83: 493-501.
3DuBois RN, Redhika A, Reddy BS, et al. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterolog, 1996,110 : 1259-1262.
4Sinierope FA, Lemoine M, Xie L, et al. Reduced expression of eyclooxygenase-2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.Gastroenterology, 1999,117:350-358.
5Williams CS, Luongo C, Radhika A, et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 1996,111 : 1134-1140.
6Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Ape (delta 716) knockout mice by inhibition of cyclooxygenase-2 ((COX-2). Cell,1996,87:803-809.
7Agoff SN, Brentnall TA, Crispin DA, et al. The role of cyclooxygenase-2 in ulcerative colitis-associated neoplasia. Am J Pathol, 2000,157 : 737-745.
8MeCartney SA, Mitchell JA, Fairclough PD, et al. Selective COX-2 inhibitors and human inflammatory bowel-disease. Aliment Pharmaeol Ther, 1999,13 : 1115-1117.
9Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and Bcl 2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res,1998,58:362-366.
10Williams CS, Watson AJ, Sheng H, et al. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res, 2000,60:6045-6051.
